Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib - Pérez-Lamas, L.; Díaz, A.S.; Casterá, E.M.; Soto, M.H.; Coll, A.P.; De las Heras, N.; Cortes, M.; Tenza, P.V.; Pacho, M.S.; Magan, A.S.; Angona, A.; Cervero, C.; et al. (Annals of Hematology, 2024)